Are childhood immunisation rates associated with per capita income? Empirical evidence from 95 countries

Cantarero-Prieto, David and Pascual-Sáez, Marta and Lanza-León, Paloma (2022): Are childhood immunisation rates associated with per capita income? Empirical evidence from 95 countries.

Abstract

Vaccination is a relevant prevention measure as a health strategy as it improves population’s health and well-being. This paper examines the relationship between trends in childhood vaccination coverage and per capita income from 2000 to 2020 and, specifically, the existence of convergence between them. We analyse data from two sources. On the one hand, we use per capita income data according to the World Bank classification (low-, lower-middle, upper-middle and high-income countries). On the other hand, we use data from the World Health Organization to analyse eight vaccines (the first dose of Bacillus Calmette–Guérin (BCG); the first and the third dose of Diphtheria-Tetanus-Pertussis (DTP1 and DTP3); the third dose of Hepatitis B (HEPB3); the first and the second dose of Measles-Containing (MCV1 and MCV2); the third dose of Polio (Pol3); and the Tetanus Toxoid (TT2)). We perform a fixed effects model to obtain the correlation between trends in coverage of the 8 vaccines mentioned and income across 95 countries during the first 20 years of the 21st century. Additionally, we follow the Barro and Sala-i-Martín approach to identify conditioned convergence. The study includes 95 countries and eight vaccines. Our findings show a positive correlation for almost all vaccines (BCG: 0.0014, p=0.0006; DTP1: 0.0012, p=0.0006; DTP3: 0.0002, p=0.0009; HepB3: 0.0037, p=0.0011; MCV1: 0.0022, p=0.0010; MCV2: -0.0062, p=0.0044; Pol3: 0.0001, p=0.0010; TT2: 0.0052, p=0.0009). Looking at conditioned convergence, the positive coefficient of the delayed dependent variable implies conditioned convergence for all vaccines (BCG: -0.1145, p=0.0073; DTP1: -0.1105, p=0.00789; DTP3: -0.1097, p=0.0070; HepB3: -0.1184, p=0.0087; MCV1: -0.1115, p=0.0075; MCV2: -0.1376, p=0.0123; Pol3: -0.1089, p=0.0070; TT2: -0.1158, p=0.0131). Hence, even if countries differ in their socioeconomic characteristics, they converge to different steady state. This paper provides new empirical evidence on both the relationship of immunisation coverage rates and per capita income. Our findings may have significant implications for health policies because socio-economic status indicators have a notable impact on immunisation rates.

• Item Type: MPRA Paper
• Language: English
• Keywords: Immunisation coverage; Childhood; Per capita income; Fixed effects model
• Subjects: I - Health, Education, and Welfare > I1 - Health > I12 - Health Behavior; I - Health, Education, and Welfare > I1 - Health > I14 - Health and Inequality

References

[1] Bloom DE, Canning D, Fink G. Disease and development revisited. J Political Econ 2014;122(6):1355-1366.

[2] World Health Organization (WHO). Assessment Report of the Global Vaccine Action Plan Strategic Advisory Group of Experts on Immunization. World Health Organization: Geneva, Switzerland.

[3] Masia NA, Smerling J, Kapfidze T, Manning R, Showalter M. Vaccination and GDP Growth Rates: Exploring the Links in a Conditional Convergence Framework. World Dev 2018;103:88-99.

[4] Lu C, Michaud CM, Gakidou E, Khan K, Murray CJ. Effect of the Global Alliance for Vaccines and Immunisation on diphtheria, tetanus, and pertussis vaccine coverage: an independent assessment. Lancet 2006;368(9541):1088-1095.

[5] Damm O, Eichner M, Rose MA, Knuf M, Wutzler P, Liese JG, Krüger H, Greiner W. Public health impact and cost-effectiveness of intranasal live attenuated influenza vaccination of children in Germany. European J of Health Econ 2015;16(5):471-488.

[6] Ozawa S, Clark S, Portnoy A, Grewal S, Brenzel L, Walker DG. Return on investment from childhood immunization in low-and middle-income countries, 2011–20. Health Aff 2016;35(2):199-207.

[7] LaMontagne DS, Barge S, Thi LeN, Mugisha E, Penny ME, Gandhi S, Janmohamed A, Kumakech E, Mosqueira NR, Nguyen NQ, Paul P, Tang Y, Minh TH, Uttekar BP, Jumaan AO. Human papillomavirus vaccine delivery strategies that achieved high coverage in low-and middle-income countries. Bull World Health Organ 2011;89:821-830.

[8] Bruni L, Diaz M, Barrionuevo-Rosas L, Herrero R, Bray F, Bosch FX, de San José S, Castellsagué X. Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis. Lancet Glob Health 2016;4(7):e453-e463.

[9] World Health Organization (WHO). Immunization data. World Health Organization: Geneva, Switzerland.

[10] Sakai Y. The Vaccination Kuznets Curve: Do vaccination rates rise and fall with income? J Health Econ 2018;57:195-205.

[11] Barro RJ, Sala-i-Martin X. Convergence. J Political Econ 1992;100(2): 223-251.

[12] Barro RJ. Convergence and modernization revisited (No. w18295). Natl Bur Econ Res 2012.

[13] MacDonald NE. Vaccine hesitancy: Definition, scope and determinants. Vaccine 2015;33(34):4161-4164.

[14] Szucs TD, Müller D. Influenza vaccination coverage rates in five European countries—a population-based cross-sectional analysis of two consecutive influenza seasons. Vaccine 2005;23(43):5055-5063.

[15] Odusanya OO, Alufohai EF, Meurice FP, Ahonkhai VI. Determinants of vaccination coverage in rural Nigeria. BMC Public Health 2008;8(1): 381.

[16] Rainey JJ, Watkins M, Ryman TK, Sandhu P, Bo A, Banerjee K. Reasons related to non-vaccination and under-vaccination of children in low and middle income countries: findings from a systematic review of the published literature, 1999–2009. Vaccine 2011;29(46):8215-8221.

[17] Williams SE, Rothman RL, Offit PA, Schaffner W, Sullivan M, Edwards KM. A randomized trial to increase acceptance of childhood vaccines by vaccine-hesitant parents: a pilot study. Acad Pediatrics 2013;13(5):475-480.

[18] Lukusa LA, Mbeye NN, Adeniyi FB, Wiysonge CS. Protocol for a systematic review of the effects of interventions to inform or educate caregivers about childhood vaccination in low and middle-income countries. BMJ 2015;5(7):e008113.

[19] Kusuma YS, Kumari R, Pandav CS, Gupta SK. Migration and immunization: determinants of childhood immunization uptake among socioeconomically disadvantaged migrants in Delhi, India. Tropical Medicine & Int Health 2010;15(11):1326-1332.

[20] Tabacchi G, Costantino C, Napoli G, Marchese V, Cracchiolo M, Casuccio A, Vitale F, Esculapio Working Group. Determinants of European parents' decision on the vaccination of their children against measles, mumps and rubella: A systematic review and meta-analysis. Hum Vaccines & Immunother 2016;12(7):1909-1923.

[21] Molina-Aguilera IB. Perspectives on the development and use of economic evidence for immunization decision-making in a developing country. Vaccine 2015;33:A6-A7.

[22] Phillips DE, Dieleman JL, Lim SS, Shearer J. Determinants of effective vaccine coverage in low and middle-income countries: a systematic review and interpretive synthesis. BMC Health Serv Res 2017, 17(1), 681.